Skip to content

Clinical trials

Active, not recruiting Lymphoma, Large B-Cell, Diffuse trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Active, not recruiting Country / region: Taiwan Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20191
20202
20214
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab5
AbbVie1
Acerta Pharma BV1
AstraZeneca1
Hoffmann-La Roche1
Incyte Corporation1
Janssen Research & Development, LLC1
Pell Bio-Med Technology Co., Ltd.1
Regeneron Pharmaceuticals1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse14
Lymphoma, Non-Hodgkin5
Neoplasms5
Lymphoma, B-Cell4
Lymphoma, Follicular3
Recurrence3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Mantle-Cell2
Bronchiolitis Obliterans Syndrome1
Leukemia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.